Home › This Tiny Biotech Hopes to Capture a Share of This $6 Billion Market
 

Keywords :   


This Tiny Biotech Hopes to Capture a Share of This $6 Billion Market

2015-02-02 16:11:55| Chemicals - Topix.net

If Ophthotech's late-stage trials pan out, Ophthotech could have a billion-dollar blockbuster drug on its hands. First, a bit of background The drug Ophthotech is developing is Fovista, a possible treatment for wet-stage, age-related macular degeneration -- one of the most common forms of vision loss among aging Americans.

Tags: this share market capture

Category:Chemicals

Latest from this category

All news
05.11Registration Now Open for RadTech 2025
05.11Teknos Poland Honored by Farby i Lakiery
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
04.11Registration Open for 2025 Waterborne Symposium
04.11ROSS Ribbon Blenders Provide Safe, Efficient Bulk Blending
04.11U.S. Green Building Council Announces 2024 Leadership Award Recipients
04.11ASTM International Publishes New Standards for FT4 Powder Rheometer Procedures
04.11Nippon Paint Marine Uses Biomimetics to Unlock Next Generation in Hull Coatings
Chemicals »
05.11NI rise hits workers harder than employers, says OBR
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 8
05.11Tropical Storm Rafael Public Advisory Number 8
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 8
05.11Lenzing Expands Nonwovens Range
05.11Netflix Europe offices raided in tax fraud probe
More »